Patient-reported outcome (PRO)-based symptom assessment in patients with advanced lung cancer receiving first-line combination immunotherapy: a protocol for a multicenter, prospective, observational study

Patient-reported outcome (PRO)-based symptom assessment in patients with advanced lung cancer receiving first-line combination immunotherapy: a protocol for a multicenter, prospective, observational study

Abstract Background Immunotherapy is currently applied in the first-line treatment regimens for numerous advanced cancers, especially advanced lung cancer. Immune-related adverse events (irAEs) resulting from immunotherapy can vary in severity and cause a substantial symptom burden to patients. Howe...

Full description

Bibliographic Details
Main Authors: Yuanle Deng, Han Hu, Rong Jia, Wei Dai, Dengfeng Wang, Purong Zhang, Peng Zhang, Kai Cheng, Jianning Tang, Yan Wen, Xiang Zhou, Qiuling Shi, Zhujuan Xiong, Jin Zhou
Format: Article
Language:English
Published: BMC 2023-05-01
Series:BMC Pulmonary Medicine
Subjects:
Patient-reported outcome
Lung cancer
Immunotherapy
Immune-related adverse events
Online Access:https://doi.org/10.1186/s12890-023-02432-5

Internet

https://doi.org/10.1186/s12890-023-02432-5

Similar Items